Jointown Pharmaceutical Group Co., Ltd (600998.SS)
CNY 5.41
(-0.18%)
CNY 5.41
(-0.18%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.31 Billion CNY | -27.21% |
| 2022 | 3.17 Billion CNY | 24.1% |
| 2021 | 2.55 Billion CNY | -20.14% |
| 2020 | 3.2 Billion CNY | 17.67% |
| 2019 | 2.72 Billion CNY | 67.55% |
| 2018 | 1.62 Billion CNY | 11.19% |
| 2017 | 1.46 Billion CNY | 13.45% |
| 2016 | 1.28 Billion CNY | -19.45% |
| 2015 | 1.6 Billion CNY | 0.27% |
| 2014 | 1.59 Billion CNY | -0.92% |
| 2013 | 1.61 Billion CNY | -1.54% |
| 2012 | 1.63 Billion CNY | 362.68% |
| 2011 | 353.5 Million CNY | -17.6% |
| 2010 | 429 Million CNY | -12.27% |
| 2009 | 489 Million CNY | 84.53% |
| 2008 | 265 Million CNY | 231.25% |
| 2007 | 80 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 1.61 Billion CNY | -15.33% |
| 2024 Q2 | 1.9 Billion CNY | -5.35% |
| 2024 Q1 | 2.01 Billion CNY | -13.94% |
| 2023 Q3 | 2.91 Billion CNY | -7.8% |
| 2023 Q4 | 2.31 Billion CNY | -20.66% |
| 2023 FY | 2.31 Billion CNY | -27.21% |
| 2023 Q1 | 3.47 Billion CNY | 9.53% |
| 2023 Q2 | 3.16 Billion CNY | -9.15% |
| 2022 FY | 3.17 Billion CNY | 24.1% |
| 2022 Q2 | 3.18 Billion CNY | 5.31% |
| 2022 Q1 | 3.02 Billion CNY | 18.08% |
| 2022 Q3 | 3.2 Billion CNY | 0.59% |
| 2022 Q4 | 3.17 Billion CNY | -0.78% |
| 2021 Q4 | 2.55 Billion CNY | -2.33% |
| 2021 Q1 | 1.89 Billion CNY | -40.79% |
| 2021 FY | 2.55 Billion CNY | -20.14% |
| 2021 Q2 | 2.16 Billion CNY | 13.99% |
| 2021 Q3 | 2.62 Billion CNY | 21.13% |
| 2020 Q3 | 2.86 Billion CNY | -0.62% |
| 2020 Q2 | 2.88 Billion CNY | 0.66% |
| 2020 Q1 | 2.86 Billion CNY | 5.11% |
| 2020 FY | 3.2 Billion CNY | 17.67% |
| 2020 Q4 | 3.2 Billion CNY | 11.9% |
| 2019 Q2 | 1.69 Billion CNY | 0.63% |
| 2019 FY | 2.72 Billion CNY | 67.55% |
| 2019 Q4 | 2.72 Billion CNY | 0.86% |
| 2019 Q1 | 1.68 Billion CNY | 3.72% |
| 2019 Q3 | 2.7 Billion CNY | 59.15% |
| 2018 FY | 1.62 Billion CNY | 11.19% |
| 2018 Q3 | 1.63 Billion CNY | 0.94% |
| 2018 Q2 | 1.61 Billion CNY | 1.25% |
| 2018 Q1 | 1.59 Billion CNY | 9.23% |
| 2018 Q4 | 1.62 Billion CNY | -0.4% |
| 2017 Q3 | 1.32 Billion CNY | 1.24% |
| 2017 Q2 | 1.31 Billion CNY | 0.95% |
| 2017 Q1 | 1.3 Billion CNY | 0.96% |
| 2017 FY | 1.46 Billion CNY | 13.45% |
| 2017 Q4 | 1.46 Billion CNY | 9.94% |
| 2016 Q1 | 2.84 Billion CNY | 77.84% |
| 2016 Q3 | 2.87 Billion CNY | 0.61% |
| 2016 Q4 | 1.28 Billion CNY | -55.18% |
| 2016 Q2 | 2.85 Billion CNY | 0.45% |
| 2016 FY | 1.28 Billion CNY | -19.45% |
| 2015 Q2 | 1.59 Billion CNY | 0.09% |
| 2015 Q1 | 1.59 Billion CNY | 0.09% |
| 2015 FY | 1.6 Billion CNY | 0.27% |
| 2015 Q4 | 1.6 Billion CNY | 0.02% |
| 2015 Q3 | 1.59 Billion CNY | 0.09% |
| 2014 Q1 | 1.61 Billion CNY | 0.03% |
| 2014 Q4 | 1.59 Billion CNY | 0.08% |
| 2014 Q3 | 1.59 Billion CNY | 0.08% |
| 2014 FY | 1.59 Billion CNY | -0.92% |
| 2014 Q2 | 1.59 Billion CNY | -1.11% |
| 2013 Q3 | 2.4 Billion CNY | 49.85% |
| 2013 FY | 1.61 Billion CNY | -1.54% |
| 2013 Q2 | 1.6 Billion CNY | 1.34% |
| 2013 Q4 | 1.61 Billion CNY | -33.16% |
| 2013 Q1 | 1.58 Billion CNY | -2.98% |
| 2012 FY | 1.63 Billion CNY | 362.68% |
| 2012 Q2 | 106 Million CNY | -22.06% |
| 2012 Q3 | 106 Million CNY | 0.0% |
| 2012 Q4 | 1.63 Billion CNY | 1442.98% |
| 2012 Q1 | 136 Million CNY | -61.53% |
| 2011 Q4 | 353.5 Million CNY | -9.48% |
| 2011 Q1 | 596 Million CNY | 38.93% |
| 2011 FY | 353.5 Million CNY | -17.6% |
| 2011 Q3 | 390.5 Million CNY | -8.12% |
| 2011 Q2 | 425 Million CNY | -28.69% |
| 2010 Q2 | 554 Million CNY | 0.0% |
| 2010 FY | 429 Million CNY | -12.27% |
| 2010 Q4 | 429 Million CNY | 0.0% |
| 2009 FY | 489 Million CNY | 84.53% |
| 2008 FY | 265 Million CNY | 231.25% |
| 2007 FY | 80 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 107.24 Million CNY | -2055.762% |
| LBX Pharmacy Chain Joint Stock Company | 1.37 Billion CNY | -67.73% |
| Yifeng Pharmacy Chain Co., Ltd. | 133.61 Million CNY | -1630.26% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 1.94 Billion CNY | -18.56% |